MDS/MPN with ring sideroblasts and thrombocytosis have been redefined in the 2022 WHO classification based on SF3B1 mutation and renamed MDS/MPN with SF3B1 mutation and thrombocytosis [107]. The gene discussed is SF3B1; the disease is myelodysplastic syndrome.